Oxford University to resume vaccine trial after pause
Published : 12 Sep 2020, 22:46
Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after being paused due to a reported side effect in a patient in the UK, reported British Broadcasting Corporation (BBC).
On Tuesday, AstraZeneca said the studies were being paused while it investigated whether the adverse reaction was linked with the vaccine.
But on Saturday, the university said it had been deemed safe to continue, said the BBC report.
British Health Secretary Matt Hancock welcomed the news that the trials would resume.
"This pause shows we will always put safety first. We will back our scientists to deliver an effective vaccine as soon as safely possible,", said the BBC report, quoting Hancock as saying.
Click BBC to read the detail original report.
EU plans to address cyberattacks in health sector
UAE mediates exchange of 50 captives between Russia, Ukraine
Lithuania sends 2 ships for NATO mission in Baltic Sea
Germany stuck in longest recession in decades
11 die from consuming counterfeit alcohol in Istanbul
Zelensky, German minister meet on military aid
Editor-in-Chief Ofiul Hasnat,
Published by Finnish News Network (FNN),
Heporinne 4 B 45
01200 Vantaa, Finland.
E-mails : [email protected]
To Editor: [email protected]